Biosimilars, which are viewed as supplements for their equivalent biologicals in terms of safety, quality and efficacy (if & when proved), are opined as value gainers in the days to come. https://www.freyrsolutions.com/blog/biosimilars-in-europe-and-the-usa-decode-market-and-regulatory-scenarios
blog directory 
